A recent study showed that golimumab (Simponi) can be effective as salvage therapy for refractory Crohn's patients who failed other anti-TNFs (like Humira and Remicade). So, it could be worth a try.
Link to the golimumab study:
/academic.oup.com/jcag/article/1/suppl_1/173/4916260